Evidence map›Paper›PMID 40980504›Full record

ArticleBioactive materials2025

Jiating Chen, Pengfei Zhang, Hongjuan Peng, Jihong Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioactive materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Veterinary sciences · 2026
    Review
  2. Free GPIs and Comparison of GPI Structures Among Species.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jiating ChenDepartment of Nephrology, The People's Hospital of Baoan Shenzhen, The Second Affiliated Hospital of Shenzhen University, Shenzhen Hospital of Guangdong Provincial People's Hospital, Shenzhen School of Clinical Medicine, Southern Medical University, Shenzhen Baoan Clinical Medical School of Guangdong Medical University, The 8th People's Hospital of Shenzhen, Baoan Clinical Research Center for Kidney Disease, Guangdong, 518000, PR China.
Pengfei ZhangGuangdong Key Laboratory of Nanomedicine, CAS-HK Joint Lab of Biomaterials, CAS Key Laboratory of Biomedical Imaging Science and System, Shenzhen Engineering Laboratory of Nanomedicine and Nanoformulations, CAS Key Lab for Health Informatics, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, PR China.
Hongjuan PengDepartment of Pathogen Biology, Guangdong Provincial Key Laboratory of Tropical Diseases Research, School of Public Health, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Southern Medical University, Guangzhou City, Guangdong Province, PR China, 510515.
Jihong ChenDepartment of Nephrology, The People's Hospital of Baoan Shenzhen, The Second Affiliated Hospital of Shenzhen University, Shenzhen Hospital of Guangdong Provincial People's Hospital, Shenzhen School of Clinical Medicine, Southern Medical University, Shenzhen Baoan Clinical Medical School of Guangdong Medical University, The 8th People's Hospital of Shenzhen, Baoan Clinical Research Center for Kidney Disease, Guangdong, 518000, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell membrane-derived nanovesicles (CMNVs) are nanoscale lipid bilayer structures obtained from cellular membranes that serve as biomimetic drug delivery platforms, offering immune evasion, targeting, and surface functionalization capabilities. While most CMNVs originate from mammalian cells,

Indexed as

Cell membrane-derived nanovesiclesGenetic engineering of nanovesiclesImmune modulationTargeted drug deliveryToxoplasma gondiiVaccines

Identifiers

PMID40980504
PMCPMC12445233

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.